JP5406040B2 - 医薬使用のためのリパーゼ変異体 - Google Patents

医薬使用のためのリパーゼ変異体 Download PDF

Info

Publication number
JP5406040B2
JP5406040B2 JP2009543078A JP2009543078A JP5406040B2 JP 5406040 B2 JP5406040 B2 JP 5406040B2 JP 2009543078 A JP2009543078 A JP 2009543078A JP 2009543078 A JP2009543078 A JP 2009543078A JP 5406040 B2 JP5406040 B2 JP 5406040B2
Authority
JP
Japan
Prior art keywords
lipase
seq
enzyme
amino acids
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009543078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512795A5 (OSRAM
JP2010512795A (ja
Inventor
スベンセン，アラン
スクヨエット，ミシェル
ヤバー，デビー
レーマン ヒュリング クリステンセン，ラーズ
エスキルセン ラーセン，シグネ
ルンディン，ニーナ
ランサ，マイケル
コリン グレゴリー，ピーター
Original Assignee
ノボザイムス アクティーゼルスカブ
ノボザイムス，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノボザイムス アクティーゼルスカブ, ノボザイムス，インコーポレイティド filed Critical ノボザイムス アクティーゼルスカブ
Publication of JP2010512795A publication Critical patent/JP2010512795A/ja
Publication of JP2010512795A5 publication Critical patent/JP2010512795A5/ja
Application granted granted Critical
Publication of JP5406040B2 publication Critical patent/JP5406040B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2009543078A 2006-12-21 2007-12-12 医薬使用のためのリパーゼ変異体 Active JP5406040B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87119606P 2006-12-21 2006-12-21
US60/871,196 2006-12-21
PCT/US2007/087168 WO2008079685A2 (en) 2006-12-21 2007-12-12 Lipase variants for pharmaceutical use

Publications (3)

Publication Number Publication Date
JP2010512795A JP2010512795A (ja) 2010-04-30
JP2010512795A5 JP2010512795A5 (OSRAM) 2011-02-03
JP5406040B2 true JP5406040B2 (ja) 2014-02-05

Family

ID=38043020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009543078A Active JP5406040B2 (ja) 2006-12-21 2007-12-12 医薬使用のためのリパーゼ変異体

Country Status (16)

Country Link
US (3) US8273348B2 (OSRAM)
EP (6) EP2261328B1 (OSRAM)
JP (1) JP5406040B2 (OSRAM)
KR (1) KR20090101930A (OSRAM)
CN (2) CN105112386A (OSRAM)
AR (1) AR064494A1 (OSRAM)
AU (1) AU2007337150A1 (OSRAM)
BR (1) BRPI0721103A2 (OSRAM)
CA (3) CA2961041C (OSRAM)
IL (1) IL198893A0 (OSRAM)
MX (1) MX2009006597A (OSRAM)
NO (1) NO20092729L (OSRAM)
RU (1) RU2009128067A (OSRAM)
TW (1) TW200829698A (OSRAM)
WO (1) WO2008079685A2 (OSRAM)
ZA (1) ZA200903598B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005227090B2 (en) 2004-03-22 2010-12-09 Abbott Laboratories Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
PL2278002T3 (pl) 2005-07-29 2017-12-29 Abbott Laboratories Gmbh Pankreatyna o zmniejszonej zawartości wirusowej
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2261328B1 (en) 2006-12-21 2013-11-20 Novozymes A/S Lipase variants for pharmaceutical use
US8637101B2 (en) 2008-02-29 2014-01-28 Dsm Ip Assets B.V. Lipases with high specificity towards short chain fatty acids and uses thereof
AR070498A1 (es) * 2008-02-29 2010-04-07 Procter & Gamble Composicion detergente que comprende lipasa
AR070491A1 (es) * 2008-02-29 2010-04-07 Novozymes As Variante de enzima lipolitica con estabilidad aumentada y polinucleotidos que la codifican
CN102652175B (zh) 2009-12-09 2016-02-10 宝洁公司 织物和家居护理产品
BR112013032861A2 (pt) 2011-07-22 2017-01-24 Novozymes North America Inc métodos para aumentar a atividade da enzima celulolítica durante a hidrólise do material celulósico, para hidrolisar um material celulósico pré-tratado, para a produção de um produto da fermentação, e para a fermentação de um material celulósico pré-tratado
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
DK3382003T3 (da) * 2011-12-29 2021-09-06 Novozymes As Detergentsammensætninger med lipasevarianter
DK3211074T3 (da) * 2012-02-03 2020-06-02 Novozymes As Lipasevarianter og polynukleotider, som koder for dem
CN104204198B (zh) * 2012-04-02 2018-09-25 诺维信公司 脂肪酶变体以及编码其的多核苷酸
EP3842531A1 (en) * 2012-10-12 2021-06-30 Danisco US Inc. Compositions and method comprising a lipolytic enzyme variant
CN115521831A (zh) 2013-05-14 2022-12-27 诺维信公司 洗涤剂组合物
ES2797483T3 (es) * 2013-07-19 2020-12-02 Danisco Us Inc Composiciones y métodos comprendiendo una variante de enzima lipolítica
US10287562B2 (en) * 2014-11-20 2019-05-14 Novoszymes A/S Alicyclobacillus variants and polynucleotides encoding same
US10457921B2 (en) 2014-12-05 2019-10-29 Novozymes A/S Lipase variants and polynucleotides encoding same
US11268076B2 (en) 2014-12-09 2022-03-08 Novozymes A/S Lipase variants and polynucleotides encoding same
US20180355404A1 (en) 2015-04-07 2018-12-13 Novozymes A/S Methods for selecting enzymes having lipase activity
US10920203B2 (en) * 2015-07-01 2021-02-16 Novozymes A/S Methods of reducing odor
CN107995922B (zh) * 2015-07-03 2021-12-28 诺维信公司 在亚硫酸盐的存在下具有改进的稳定性的洗涤剂组合物
EP3485008B1 (en) 2016-07-18 2024-01-31 Novozymes A/S Lipase variants, polynucleotides encoding same and the use thereof
CN110462037A (zh) * 2017-01-30 2019-11-15 学校法人日本医科大学 腺相关病毒(aav)衣壳蛋白的突变体
US11286443B2 (en) * 2017-09-27 2022-03-29 The Procter & Gamble Company Detergent compositions comprising lipases
CN117448299A (zh) 2017-09-27 2024-01-26 诺维信公司 脂肪酶变体和包含此类脂肪酶变体的微囊组合物
US20210071157A1 (en) * 2018-02-08 2021-03-11 Novozymes A/S Lipase Variants and Compositions Thereof
CA3109082A1 (en) * 2018-08-16 2020-02-20 Isolere Bio, Inc. Genetically encoded polypeptide for affinity capture and purification of biologics
CN111334369B (zh) * 2020-03-11 2022-10-21 陕西科技大学 一种酶法制备卵磷脂型pufa的方法
CN115803083A (zh) * 2020-06-24 2023-03-14 基利安股份公司 新脂肪酶
US20240035005A1 (en) * 2020-10-29 2024-02-01 Novozymes A/S Lipase variants and compositions comprising such lipase variants
CN113846074B (zh) * 2021-10-20 2022-10-21 南京林业大学 一种疏棉状嗜热丝孢菌脂肪酶突变体g91c及其应用
EP4525615A2 (en) 2022-05-14 2025-03-26 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
EP4544015A2 (en) * 2022-06-24 2025-04-30 Novozymes A/S Lipase variants and compositions comprising such lipase variants

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
DK46693D0 (OSRAM) 1993-04-23 1993-04-23 Novo Nordisk As
US5869438A (en) 1990-09-13 1999-02-09 Novo Nordisk A/S Lipase variants
CA2092615A1 (en) * 1990-09-13 1992-03-14 Allan Svendsen Lipase variants
WO1992010755A1 (en) 1990-12-05 1992-06-25 Novo Nordisk A/S Proteins with changed epitopes and methods for the production thereof
EP0585285B1 (en) 1991-05-01 1998-08-12 Novo Nordisk A/S Stabilized enzymes
DK39693D0 (da) 1993-04-02 1993-04-02 Novo Nordisk As Enzym
AU7807394A (en) 1993-10-04 1995-05-01 Novo Nordisk A/S An enzyme preparation comprising a modified enzyme
ATE222604T1 (de) 1994-02-22 2002-09-15 Novozymes As Methode zur herstellung einer variante eines lipolytischen enzymes
JPH10509324A (ja) 1994-11-24 1998-09-14 ノボ ノルディスク アクティーゼルスカブ 抑制されたアレルゲン性を有するポリペプチドの製造のための方法
EP0796324A1 (en) 1994-12-07 1997-09-24 Novo Nordisk A/S Polypeptide with reduced allergenicity
CA2209617C (en) 1995-01-26 2002-05-28 Novo Nordisk A/S Animal feed additives comprising xylanase
US6495357B1 (en) * 1995-07-14 2002-12-17 Novozyme A/S Lipolytic enzymes
CN1193346A (zh) 1995-07-14 1998-09-16 诺沃挪第克公司 一种具有脂解活性的修饰酶
CN1192780B (zh) 1995-08-11 2010-08-04 诺沃奇梅兹有限公司 新的脂解酶
WO1998030682A1 (en) 1997-01-10 1998-07-16 Novo Nordisk A/S Enzyme coupled with polymeric molecules for skin care
EP1017794A1 (en) 1997-02-06 2000-07-12 Novo Nordisk A/S Polypeptide-polymer conjugates having added and/or removed attachment groups
ATE375387T1 (de) 1997-06-25 2007-10-15 Novozymes As Modifiziertes polypeptid
AU3247699A (en) 1998-02-17 1999-09-06 Novo Nordisk A/S Lipase variant
CN1247776C (zh) * 1998-02-17 2006-03-29 诺维信公司 脂肪酶变体
CN1323345A (zh) 1998-10-13 2001-11-21 诺沃奇梅兹有限公司 具有降低的免疫应答的修饰多肽
NZ511291A (en) 1998-10-30 2003-08-29 Novozymes As A method for selecting a protein variant that has reduced immunogenicity as compared with the parent or wild-type protein
AU774156B2 (en) 1998-10-30 2004-06-17 Novozymes A/S Glycosylated proteins having reduced allergenicity
NZ511340A (en) 1998-11-27 2003-07-25 Novozymes As Lipolytic enzyme variants
US7312062B2 (en) * 1998-11-27 2007-12-25 Novozymes A/S Lipolytic enzyme variants
JP4938174B2 (ja) 1999-03-17 2012-05-23 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病を治療するための医薬品
EP1171581A1 (en) * 1999-03-31 2002-01-16 Novozymes A/S Lipase variant
EP2278000A1 (en) 1999-03-31 2011-01-26 Novozymes A/S Lipase variant
PL203212B1 (pl) 2000-02-08 2009-09-30 Dsm Ip Assets Bv Zastosowanie trwałej w kwasie proteazy w karmie zwierzęcej oraz w wytwarzaniu kompozycji do stosowania w karmie zwierzęcej, dodatek do karmy zwierzęcej, kompozycja karmy zwierzęcej i sposób obróbki białek roślinnych
US20020192792A1 (en) * 2000-04-28 2002-12-19 Palle Schneider Laccase mutants
ES2323947T3 (es) 2001-01-10 2009-07-28 Novozymes A/S Variante de enzima lipolitica.
AR032392A1 (es) 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
EP1360278B1 (en) 2001-02-07 2009-09-23 Novozymes A/S Lipase variants
EP2295556B1 (en) * 2002-01-16 2014-10-29 Novozymes A/S Lipolytic enzymes variants and methods for their production
BRPI0407108A (pt) 2003-02-06 2006-01-24 Novozymes As Método para produzir uma imunoglobulina funcional humana
EP1625216B1 (en) 2003-05-09 2012-11-21 Novozymes A/S Variant lipolytic enzymes
US20060251763A1 (en) 2003-06-19 2006-11-09 Patkar Shamkant A Phospholipase variants
DK1639107T3 (da) 2003-06-19 2013-11-18 Novozymes As Forbedrede proteaser og fremgangsmåder til fremstilling deraf
CA2553731A1 (en) 2004-01-21 2005-08-04 Novozymes A/S Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell
AU2005227090B2 (en) 2004-03-22 2010-12-09 Abbott Laboratories Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
DK1809320T3 (da) 2004-10-14 2010-11-15 Cystic Fibrosis Foundation The Præparater indeholdende lipase, protease og amylase til behandling af pankreatisk insufficiens
US20080138856A1 (en) 2005-02-10 2008-06-12 Novozymes A/S Enzymatic Enantioselective Ester or Amide Hydrolysis or Synthesis
MX2007015471A (es) 2005-06-24 2008-04-04 Novozymes As Amilasas para uso farmaceutico.
MX2007015474A (es) 2005-06-24 2008-04-22 Novozymes As Proteasas para uso farmaceutico.
WO2006136159A2 (en) 2005-06-24 2006-12-28 Novozymes A/S Lipases for pharmaceutical use
WO2007080197A2 (en) * 2006-01-16 2007-07-19 Novozymes A/S Immobilised enzymes
ES2629334T3 (es) * 2006-01-23 2017-08-08 Novozymes A/S Variantes de lipasa
WO2007087242A2 (en) * 2006-01-23 2007-08-02 The Procter & Gamble Company A composition comprising a lipase and a bleach catalyst
EP2261328B1 (en) * 2006-12-21 2013-11-20 Novozymes A/S Lipase variants for pharmaceutical use

Also Published As

Publication number Publication date
EP2455459B1 (en) 2016-03-16
US20120308543A1 (en) 2012-12-06
CN101743308A (zh) 2010-06-16
US9539311B2 (en) 2017-01-10
BRPI0721103A2 (pt) 2014-03-04
EP2261328A1 (en) 2010-12-15
EP2455462B1 (en) 2016-03-16
EP2455462A3 (en) 2013-05-29
US9029115B2 (en) 2015-05-12
EP2261328B1 (en) 2013-11-20
US20150209414A1 (en) 2015-07-30
CA3081308C (en) 2024-02-20
KR20090101930A (ko) 2009-09-29
EP2455460A2 (en) 2012-05-23
CA2670643C (en) 2017-04-25
EP2455460A3 (en) 2012-12-26
US8273348B2 (en) 2012-09-25
CA2670643A1 (en) 2008-07-03
WO2008079685A3 (en) 2008-11-06
EP2455462A2 (en) 2012-05-23
EP2455461A2 (en) 2012-05-23
EP2455459A2 (en) 2012-05-23
CN101743308B (zh) 2015-09-16
TW200829698A (en) 2008-07-16
RU2009128067A (ru) 2011-01-27
EP2099907A2 (en) 2009-09-16
CN105112386A (zh) 2015-12-02
MX2009006597A (es) 2009-07-02
AR064494A1 (es) 2009-04-08
US20100034797A1 (en) 2010-02-11
NO20092729L (no) 2009-09-18
CA2961041A1 (en) 2008-07-03
EP2455461B1 (en) 2016-03-16
IL198893A0 (en) 2010-02-17
CA2961041C (en) 2020-07-14
EP2455459A3 (en) 2013-04-24
ZA200903598B (en) 2010-04-28
AU2007337150A1 (en) 2008-07-03
WO2008079685A2 (en) 2008-07-03
CA3081308A1 (en) 2008-07-03
EP2455461A3 (en) 2013-05-29
JP2010512795A (ja) 2010-04-30

Similar Documents

Publication Publication Date Title
JP5406040B2 (ja) 医薬使用のためのリパーゼ変異体
US20090047266A1 (en) Lipases for Pharmaceutical Use
JP2008546396A (ja) 薬学的に使用するためのアミラーゼ
US8455235B2 (en) Protease variants for pharmaceutical use
AU2013203500B2 (en) Lipase variants for pharmaceutical use
AU2013200626B2 (en) Lipase variants for pharmaceutical use
HK1141553A (en) Lipase variants for pharmaceutical use
HK1113174A (en) Lipases for pharmaceutical use
HK1145697A (en) Protease variants for pharmaceutical use

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101210

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101210

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20111219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20111219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130717

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131001

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131031

R150 Certificate of patent or registration of utility model

Ref document number: 5406040

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250